Cargando...

A Pilot Pharmacologic Biomarker Study in HLA-Haploidentical Hematopoietic Cell Transplant Recipients

PURPOSE: Eleven patients diagnosed with various hematologic malignancies receiving an HLA-haploidentical hematopoietic cell transplant (HCT) participated in an ancillary biomarker trial. The goal of the trial was to evaluate potential pharmacologic biomarkers pertinent to the conditioning regimen (f...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bemer, Meagan J., Sorror, Mohamed, Sandmaier, Brenda M., O’Donnell, Paul V., McCune, Jeannine S.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786586/
https://ncbi.nlm.nih.gov/pubmed/23907443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2232-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!